Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab.

Background: Rituximab (RTX) and ocrelizumab (OCR), B cell-depleting therapy targeting CD20 molecules, affect the humoral immune response after vaccination. How these therapies influence T-cell-mediated immune response against SARS-CoV-2 after immunization remains unclear. We aimed to evaluate the humoral and cellular immune response to the COVID-19 vaccine in a cohort of patients with multiple sclerosis (MS), neuromyelitis optica spectrum disorders (NMOSD), and myasthenia gravis (MG).

[Detection of Francisella tularensis by blood culture].

Francisella tularensis, from the family Francisellaceae, is the aetiological agent of a zoonosis called tularaemia, spread throughout the northern hemisphere. The infectious dose is extremely low (10 CFU/ml) and the infection causes severe diseases or even death if untreated. The transmission to humans is always related to animals, either by a direct contact or by a contact with the environment contaminated by them.

[Tularaemia - an overview of the current knowledge].

Francisella tularensis belongs to the family Francisellaceae. It is the aetiological agent of a zoonosis called tularaemia, spread throughout the northern hemisphere. Currently, several subspecies of F.